SGAs in Youth With Bipolar Depression

<p>What are the safest and most effective medications for depression in youth with bipolar disorder? In this episode, we compare the response rates of quetiapine, olanzapine, and lurasidone for bipolar depression in youth. This episode also explains the differences in metabolic side effects and discusses the limitations of this study. </p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC198" target="_blank" rel="noopener">Learn more about our memberships here</a></strong></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-01-2740?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC198" target="_blank" rel="noopener">Earn 0.5 CMEs: Smart Take Vol. 01</a></strong></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/section/efficacy-and-safety-of-sgas-in-youth-with-bipolar-depression-2740-5285?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC198" target="_blank" rel="noopener">Efficacy and Safety of SGAs in Youth With Bipolar Depression</a></strong></li> </ul>